How much is IDRx worth in 2026?

IDRx has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has IDRx raised?

IDRx has raised N/A in total funding across 1 funding rounds.

IDRx

Drug Discovery

IDRx valuation and funding history | Last updated: August 5, 2024 | 1 funding rounds

Current Valuation

N/A

As of August 5, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$120.0M

Last Funding

Aug 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 5, 2024	Early Stage VC (Series B)	$120.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

IDRx is currently valued at N/A as of August 5, 2024.

Track IDRx Valuation Updates

Get notified when IDRx raises new funding or valuation changes

Explore More Data

Detailed analysis for IDRx

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock IDRx's valuation history, funding rounds, and growth metrics.

No credit card required

What is IDRx Worth in 2026?

IDRx is a leading private company in the Drug Discovery sector. Track IDRx's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How IDRx Valuation is Determined

Private company valuations like IDRx's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.